The Enterprise Value as of September 2024 (TTM) for Renalytix Plc (RNLX) is 25.28M

According to Renalytix Plc’s latest financial reports and current stock price. The company's current Enterprise Value is 25.28M. This represents a change of -61.65% compared to the average of 65.92M of the last 4 quarters.

Renalytix Plc (RNLX) Historical Enterprise Value (quarterly & annually)

How has RNLX Enterprise Value performed in the past?

The mean historical Enterprise Value of Renalytix Plc over the last ten years is 372.29M. The current 25.28M Enterprise Value has changed 579.09% with respect to the historical average. Over the past ten years (40 quarters), RNLX's Enterprise Value was at its highest in in the March 2021 quarter at 854.39M. The Enterprise Value was at its lowest in in the December 2001 quarter at 0.

Renalytix Plc (RNLX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Renalytix Plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Renalytix Plc (RNLX) Average Enterprise Value

How has RNLX Enterprise Value performed in the past?

The current Enterprise Value of Renalytix Plc (RNLX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Renalytix Plc (RNLX) Enterprise Value vs. Peers

How is RNLX’s Enterprise Value compared to its peers?

Renalytix Plc’s Enterprise Value is less than Streamline Health Solutions, Inc. (2.33B), less than HealthStream, Inc. (848.10M), less than National Research Corporation (568.10M), less than Computer Programs and Systems, Inc. (279.42M), less than NextGen Healthcare, Inc. (1.83B), less than Forian Inc. (90.95M), less than Tabula Rasa HealthCare, Inc. (557.62M), greater than Aclarion, Inc. (1.22M), greater than Mangoceuticals, Inc. (7.58M), greater than Science 37 Holdings, Inc. (-21164022.00), greater than Akili, Inc. (-15651464.00), less than Augmedix, Inc. (112.47M), less than HealthEquity, Inc. (7.65B), less than Health Catalyst, Inc. (562.28M), less than Progyny, Inc. (2.13B), less than R1 RCM Inc. (8.19B),

Build a custom stock screener for Renalytix Plc (RNLX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Renalytix Plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Renalytix Plc (RNLX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Renalytix Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.